Atlas Trials

Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis

Clinical trial NCT03594487 · TERMINATED

Trial details

NCT number
NCT03594487
Sponsor
Jeffrey Gelfand
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsing Remitting Multiple Sclerosis
Start date
2018-11-16
Primary completion
2024-12-16
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.